PRMT5 and mantle cell lymphoma: Consistently, single-cell RNA-seq analysis displayed increased expression of PRMT5 and WDR77 (encoding MEP50) in clinical specimens from MCL patients who were resistant to ibrutinib or the CAR T-cell therapy (Supplementary Fig. S2f, g).